SEPARATION AGREEMENT AND RELEASESeparation Agreement • August 15th, 2005 • Xcyte Therapies Inc • Pharmaceutical preparations • Washington
This Separation Agreement and Release (“Agreement”) is entered into as of this fifteenth day of July, 2005 (hereinafter “Execution Date”) by and between Mark Frohlich (hereinafter “Employee”), and Xcyte Therapies, Inc., its affiliates, successors and assigns (hereinafter the “Company”). Employee and the Company are sometimes collectively referred to as the “Parties.”
AMENDMENT TO EMPLOYMENT AGREEMENTEmployment Agreement • August 15th, 2005 • Xcyte Therapies Inc • Pharmaceutical preparations
This Amendment to Employment Agreement (this “Amendment”) by and between Xcyte Therapies, Inc., a Delaware corporation (the “Company”) and Robert Lawrence Kirkman, M.D. (the “Employee”) is dated as of August 12, 2005 and amends the Employment Agreement, dated as of January 15, 2004 (the “Employment Agreement”) by and between the Company and the Employee. All capitalized terms used but not defined in this Amendment shall have the meanings assigned to such terms in the Employment Agreement.
XCYTE THERAPIES, INC. RETENTION AND SEPARATION AGREEMENTRetention and Separation Agreement • August 15th, 2005 • Xcyte Therapies Inc • Pharmaceutical preparations
This Retention and Separation Agreement (the “Agreement”) is dated as of July 26, 2005 (the “Effective Date”), by and between Kathi Lynn Cordova (“Employee”) and Xcyte Therapies, Inc., a Delaware corporation (the “Company”), and sets forth the terms and conditions with respect to Employee’s employment with the Company as of and after the date of this Agreement.
